🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Foojan Zeine

Health Awareness (United States)

ORCID: 0009-0006-7709-5580

Also affiliated with California State University, Long Beach

NeuroscienceMedicinePsychologyBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

0in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 9 papers. Top paper: “Solving the Global Opioid Crisis: Incorporating Genetic Addiction Risk Assessment with Personalized Dopaminergic Homeostatic Therapy and Awareness Integration Therapy”.

Solving the Global Opioid Crisis: Incorporating Genetic Addiction Risk Assessment with Personalized Dopaminergic Homeostatic Therapy and Awareness Integration Therapy

Journal of Addiction Psychiatry(2024)10.17756/jap.2024-045
N/A
0.208DataRank · unranked
3 citations

Nicole Jafari, David Baron, Abdalla Bowirrat, Albert Pinhasov, Brian Norling +37 more

Invited Expert Opinion- Bio-informatic and Limitation Di-rectives to Help Adopt Ge-netic Addiction Risk Screening and Identify Preaddictive Reward Dysregulation: Re-quired Analytic Evidence to Induce Dopamine Homeo-statsis

Medical Research Archives(2023)10.18103/mra.v11i8.4211
N/A
0.208DataRank · unranked
3 citations

Mark S. Gold, Jean Lud Cadet, Marjorie Lewis, Thomas McLaughlin, Eric R. Braverman +20 more

Are We Getting High Cause the Thrill is Gone?

Journal of Addiction Psychiatry(2023)10.17756/jap.2023-041
N/A
0.104DataRank · unranked
1 citations

Thomas McLaughlin, Mark S. Gold, Marjorie C. Gondré‐Lewis, Panayotis K. Thanos, Igor Elman +15 more

Targeting pro-dopaminergic agonism to attenuate depression in patients displaying genetic/epigenetic predisposition to hypodopaminergia

Frontiers in Public Health(2025)10.3389/fpubh.2025.1594872
N/A
0DataRank · unranked
1 citations

Kenneth Blum, Alexander P. L. Lewandrowski, Panayotis K. Thanos, Albert Pinhasov, Alireza Sharafshah +19 more

Addiction Risk Polymorphisms Links Autism Spectrum Disorder with Reward Deficiency Syndrome: Insights from GWAS and Pharmacogenomic Meta Analyses

Preprints.org(2025)10.20944/preprints202507.0381.v1
N/A
0DataRank · unranked
0 citations

Kenneth Blum, Kavya Mohankumar, Milan Makale, Abdalla Bowirrat, Albert Pinhasov +23 more

GLP-1 Agonists Can Be Heaven or Hell Dependent Upon Dopaminergic Genetic/Epigenetic Antecedents

Preprints.org(2025)10.20944/preprints202510.1849.v1
N/A
0DataRank · unranked
0 citations

Shaurya Mahajan, Alireza Sharafshah, Keerthy Sunder, Kai‐Uwe Lewandrowski, Kavya Mohankumar +22 more

Computational GWAS Meta Meta Analysis Revealing Cross Talk Between Cannabis CNR1 and DRD2 Receptors Optimizing Long-Term Outcomes for Cannabis Use Disorder (CUD) By Enhancing Dopamine Homeostasis Promoting High-Quality Cannabis Medicinals

Research Square(2025)10.21203/rs.3.rs-8140327/v1
N/A
0DataRank · unranked
0 citations

Alireza Sharafshah, Jag Khalsa, Kai-Uwe Lewandrowski, Panayotis K. Thanos, Marco Lindenau +33 more

Addictive Behavior and Evolutionary Adaptation: Mitigated through Genetic Addiction Risk Severity Early Identification and Awareness Integration Theory

Medical Research Archives(2024)10.18103/mra.v12i8.5702
N/A
0DataRank · unranked
1 citations

Nicole Jafari, Eileen Manoukian, Kenneth Blum, Foojan Zeine

The First Pilot Epigenetic Type Improvement of Neuropsychiatric Symptoms in a Polymorphic Dopamine D2 (-DRD2/ANKK (Taq1A)), OPRM1 (A/G), DRD3 (C/T), and MAOA (4R) Compromised Preadolescence Male with Putative PANDAS/CANS: Positive Clinical Outcome with Precision-Guided DNA Testing and Pro-Dopamine Regulation (KB220) and Antibacterial Therapies

Open Journal of Immunology(2024)10.4236/oji.2024.143006
N/A
0DataRank · unranked
2 citations

Igor Elman, David Han, Colin Hanna, David Baron, Ashim Gupta +21 more